Your browser doesn't support javascript.
loading
Abundance and prevalence of ESBL coding genes in patients undergoing first line eradication therapy for Helicobacter pylori.
Gudra, Dita; Silamikelis, Ivars; Pjalkovskis, Janis; Danenberga, Ilva; Pupola, Darta; Skenders, Girts; Ustinova, Maija; Megnis, Kaspars; Leja, Marcis; Vangravs, Reinis; Fridmanis, Davids.
  • Gudra D; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Silamikelis I; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Pjalkovskis J; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Danenberga I; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Pupola D; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
  • Skenders G; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
  • Ustinova M; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Megnis K; Latvian Biomedical Research and Study Centre, Riga, Latvia.
  • Leja M; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
  • Vangravs R; Faculty of Medicine, University of Latvia, Riga, Latvia.
  • Fridmanis D; Institute of Clinical and Preventive Medicine, University of Latvia, Riga, Latvia.
PLoS One ; 18(8): e0289879, 2023.
Article en En | MEDLINE | ID: mdl-37561723
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Klebsiella / Helicobacter pylori Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por Klebsiella / Helicobacter pylori Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Humans Idioma: En Año: 2023 Tipo del documento: Article